Survivin mRNA Antagonist EZN-3042

A locked nucleic acid (LNA) antisense oligonucleotide targeting survivin mRNA, with potential antineoplastic activity. EZN-3042 hybridizes to survivin mRNA, thereby blocking translation of survivin protein and inhibiting survivin-induced anti-apoptotic activity and promoting tumor cell apoptosis in survivin-overexpressing tumor cells. Survivin, a member of the inhibitor of apoptosis (IAP) family expressed during embryonic development, is upregulated in a variety of human cancers while absent in most normal adult cells; its expression in tumors is associated with a more aggressive phenotype, decreased survival, and increased resistance to chemotherapy. LNAs contain a methylene bridge linking 2'-oxygen and 4'-carbon of ribose sugar rings, thereby increasing their stability and decreasing degradation. (NCI Thesaurus)

YOU MAY ALSO LIKE

Survivin Antigen Vaccine DPX-Survivac

A lipid depot-based therapeutic cancer vaccine composed of survivin epitopes, a universal T Helper peptide and a polynucleotide adjuvant encapsulated in liposomes…

Survivin Antigen

A tumor-associated antigen. Vaccination with survivin antigen may result in a cytotoxic T-cell response against survivin antigen-expressing tumor cells, resulting in decreased…

Survival rate

The percentage of people in a study or treatment group who are still alive for a certain period of time after they…

Survival

Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.

Survey Shared Resource

The Survey Shared Resource provides Cancer Center investigators with support in the survey methodology and conduct, questionnaires development, data quality control, database…

Survey Mile

A traditional unit of distance equal to 5280 survey feet or to approximately 1609.347 meters. This unit is used for geodetic purposes…